Global Cell Therapy Market 2025-2029

Publisher TechNavio

Published Jul 10, 2025

Length 218 Pages

SKU # INF20212836

Description

Cell Therapy Market 2025-2029

The cell therapy market is forecasted to grow by USD 15253 mn during 2024-2029, accelerating at a CAGR of 21.7% during the forecast period. The report on the cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by limitations in traditional organ transplantations fueling demand for cell therapies, increasing funding in cell-based research, and proven effectiveness of car t-cell therapy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's cell therapy market is segmented as below:

By Type

Autologous
Allogenic

By Application

Malignancies
Musculoskeletal
Cardiovascular
Others

By End-user

Biopharmaceutical companies
CMOs
CROs
Academic and research institutes

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing focus on cell therapy products as one of the prime reasons driving the cell therapy market growth during the next few years. Also, strategic alliances in cell therapy market and rise in vaccine production will lead to sizable demand in the market.

The report on the cell therapy market covers the following areas:

Cell Therapy Market sizing
Cell Therapy Market forecast
Cell Therapy Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell therapy market vendors that include Astellas Pharma Inc., Athersys Inc., Avita Medical Inc., BioCardia Inc., BioSenic SA, Brainstorm Cell Therapeutics Inc., Bristol Myers Squibb Co., Capricor Therapeutics Inc., Castle Creek Biosciences Inc., CellSeed Inc., Cellular Biomedicine Group Inc., Celyad Oncology SA, Gilead Sciences Inc., Lineage Cell Therapeutics Inc., Mesoblast Ltd., Novartis AG, Pharmicell Co. Ltd., Sanpower Group Co. Ltd., and ThermoGenesis Holdings Inc.. Also, the cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Cell Therapy Market 2019 - 2023; Historic Market Size - Data Table on Global Cell Therapy Market 2019 - 2023 ($ million); 5.2 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.3 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ million); 5.4 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ million); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 The impact of AI in the global cell therapy market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type: 8.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 8.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 8.3 Autologous - Market size and forecast 2024-2029; Chart on Autologous - Market size and forecast 2024-2029 ($ million); Data Table on Autologous - Market size and forecast 2024-2029 ($ million); Chart on Autologous - Year-over-year growth 2024-2029 (%); Data Table on Autologous - Year-over-year growth 2024-2029 (%); 8.4 Allogenic - Market size and forecast 2024-2029; Chart on Allogenic - Market size and forecast 2024-2029 ($ million); Data Table on Allogenic - Market size and forecast 2024-2029 ($ million); Chart on Allogenic - Year-over-year growth 2024-2029 (%); Data Table on Allogenic - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Application: 9.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 9.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 9.3 Malignancies - Market size and forecast 2024-2029; Chart on Malignancies - Market size and forecast 2024-2029 ($ million); Data Table on Malignancies - Market size and forecast 2024-2029 ($ million); Chart on Malignancies - Year-over-year growth 2024-2029 (%); Data Table on Malignancies - Year-over-year growth 2024-2029 (%); 9.4 Musculoskeletal - Market size and forecast 2024-2029; Chart on Musculoskeletal - Market size and forecast 2024-2029 ($ million); Data Table on Musculoskeletal - Market size and forecast 2024-2029 ($ million); Chart on Musculoskeletal - Year-over-year growth 2024-2029 (%); Data Table on Musculoskeletal - Year-over-year growth 2024-2029 (%); 9.5 Cardiovascular - Market size and forecast 2024-2029; Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million); Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million); Chart on Cardiovascular - Year-over-year growth 2024-2029 (%); Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%); 9.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.7 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
10 Market Segmentation by End-user: 10.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 10.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 10.3 Biopharmaceutical companies - Market size and forecast 2024-2029; Chart on Biopharmaceutical companies - Market size and forecast 2024-2029 ($ million); Data Table on Biopharmaceutical companies - Market size and forecast 2024-2029 ($ million); Chart on Biopharmaceutical companies - Year-over-year growth 2024-2029 (%); Data Table on Biopharmaceutical companies - Year-over-year growth 2024-2029 (%); 10.4 CMOs - Market size and forecast 2024-2029; Chart on CMOs - Market size and forecast 2024-2029 ($ million); Data Table on CMOs - Market size and forecast 2024-2029 ($ million); Chart on CMOs - Year-over-year growth 2024-2029 (%); Data Table on CMOs - Year-over-year growth 2024-2029 (%); 10.5 CROs - Market size and forecast 2024-2029; Chart on CROs - Market size and forecast 2024-2029 ($ million); Data Table on CROs - Market size and forecast 2024-2029 ($ million); Chart on CROs - Year-over-year growth 2024-2029 (%); Data Table on CROs - Year-over-year growth 2024-2029 (%); 10.6 Academic and research institutes - Market size and forecast 2024-2029; Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million); Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million); Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%); Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%); 10.7 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.9 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.10 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.11 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.12 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.14 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ million); Data Table on Italy - Market size and forecast 2024-2029 ($ million); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.15 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ million); Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 12.16 Spain - Market size and forecast 2024-2029; Chart on Spain - Market size and forecast 2024-2029 ($ million); Data Table on Spain - Market size and forecast 2024-2029 ($ million); Chart on Spain - Year-over-year growth 2024-2029 (%); Data Table on Spain - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 Astellas Pharma Inc.; Astellas Pharma Inc. - Overview; Astellas Pharma Inc. - Product / Service; Astellas Pharma Inc. - Key offerings; SWOT; 15.5 Athersys Inc.; Athersys Inc. - Overview; Athersys Inc. - Product / Service; Athersys Inc. - Key offerings; SWOT; 15.6 Avita Medical Inc.; Avita Medical Inc. - Overview; Avita Medical Inc. - Product / Service; Avita Medical Inc. - Key offerings; SWOT; 15.7 BioCardia Inc.; BioCardia Inc. - Overview; BioCardia Inc. - Product / Service; BioCardia Inc. - Key offerings; SWOT; 15.8 BioSenic SA; BioSenic SA - Overview; BioSenic SA - Product / Service; BioSenic SA - Key offerings; SWOT; 15.9 Brainstorm Cell Therapeutics Inc.; Brainstorm Cell Therapeutics Inc. - Overview; Brainstorm Cell Therapeutics Inc. - Product / Service; Brainstorm Cell Therapeutics Inc. - Key offerings; SWOT; 15.10 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 15.11 Capricor Therapeutics Inc.; Capricor Therapeutics Inc. - Overview; Capricor Therapeutics Inc. - Product / Service; Capricor Therapeutics Inc. - Key offerings; SWOT; 15.12 Castle Creek Biosciences Inc.; Castle Creek Biosciences Inc. - Overview; Castle Creek Biosciences Inc. - Product / Service; Castle Creek Biosciences Inc. - Key offerings; SWOT; 15.13 CellSeed Inc.; CellSeed Inc. - Overview; CellSeed Inc. - Product / Service; CellSeed Inc. - Key offerings; SWOT; 15.14 Cellular Biomedicine Group Inc.; Cellular Biomedicine Group Inc. - Overview; Cellular Biomedicine Group Inc. - Product / Service; Cellular Biomedicine Group Inc. - Key offerings; SWOT; 15.15 Celyad Oncology SA; Celyad Oncology SA - Overview; Celyad Oncology SA - Product / Service; Celyad Oncology SA - Key offerings; SWOT; 15.16 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; SWOT; 15.17 Lineage Cell Therapeutics Inc.; Lineage Cell Therapeutics Inc. - Overview; Lineage Cell Therapeutics Inc. - Product / Service; Lineage Cell Therapeutics Inc. - Key offerings; SWOT; 15.18 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis
360 degree market analysis: 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Market Segmentation by End-user; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global Cell Therapy Market 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Application Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Type - Market share 2024-2029 (%); Exhibits39: Data Table on Type - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Type; Exhibits41: Data Table on Comparison by Type; Exhibits42: Chart on Autologous - Market size and forecast 2024-2029 ($ million); Exhibits43: Data Table on Autologous - Market size and forecast 2024-2029 ($ million); Exhibits44: Chart on Autologous - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on Autologous - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Allogenic - Market size and forecast 2024-2029 ($ million); Exhibits47: Data Table on Allogenic - Market size and forecast 2024-2029 ($ million); Exhibits48: Chart on Allogenic - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Allogenic - Year-over-year growth 2024-2029 (%); Exhibits50: Market opportunity by Type ($ million); Exhibits51: Data Table on Market opportunity by Type ($ million); Exhibits52: Chart on Application - Market share 2024-2029 (%); Exhibits53: Data Table on Application - Market share 2024-2029 (%); Exhibits54: Chart on Comparison by Application; Exhibits55: Data Table on Comparison by Application; Exhibits56: Chart on Malignancies - Market size and forecast 2024-2029 ($ million); Exhibits57: Data Table on Malignancies - Market size and forecast 2024-2029 ($ million); Exhibits58: Chart on Malignancies - Year-over-year growth 2024-2029 (%); Exhibits59: Data Table on Malignancies - Year-over-year growth 2024-2029 (%); Exhibits60: Chart on Musculoskeletal - Market size and forecast 2024-2029 ($ million); Exhibits61: Data Table on Musculoskeletal - Market size and forecast 2024-2029 ($ million); Exhibits62: Chart on Musculoskeletal - Year-over-year growth 2024-2029 (%); Exhibits63: Data Table on Musculoskeletal - Year-over-year growth 2024-2029 (%); Exhibits64: Chart on Cardiovascular - Market size and forecast 2024-2029 ($ million); Exhibits65: Data Table on Cardiovascular - Market size and forecast 2024-2029 ($ million); Exhibits66: Chart on Cardiovascular - Year-over-year growth 2024-2029 (%); Exhibits67: Data Table on Cardiovascular - Year-over-year growth 2024-2029 (%); Exhibits68: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits69: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits70: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits71: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits72: Market opportunity by Application ($ million); Exhibits73: Data Table on Market opportunity by Application ($ million); Exhibits74: Chart on End-user - Market share 2024-2029 (%); Exhibits75: Data Table on End-user - Market share 2024-2029 (%); Exhibits76: Chart on Comparison by End-user; Exhibits77: Data Table on Comparison by End-user; Exhibits78: Chart on Biopharmaceutical companies - Market size and forecast 2024-2029 ($ million); Exhibits79: Data Table on Biopharmaceutical companies - Market size and forecast 2024-2029 ($ million); Exhibits80: Chart on Biopharmaceutical companies - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Biopharmaceutical companies - Year-over-year growth 2024-2029 (%); Exhibits82: Chart on CMOs - Market size and forecast 2024-2029 ($ million); Exhibits83: Data Table on CMOs - Market size and forecast 2024-2029 ($ million); Exhibits84: Chart on CMOs - Year-over-year growth 2024-2029 (%); Exhibits85: Data Table on CMOs - Year-over-year growth 2024-2029 (%); Exhibits86: Chart on CROs - Market size and forecast 2024-2029 ($ million); Exhibits87: Data Table on CROs - Market size and forecast 2024-2029 ($ million); Exhibits88: Chart on CROs - Year-over-year growth 2024-2029 (%); Exhibits89: Data Table on CROs - Year-over-year growth 2024-2029 (%); Exhibits90: Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million); Exhibits91: Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million); Exhibits92: Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%); Exhibits93: Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%); Exhibits94: Market opportunity by End-user ($ million); Exhibits95: Data Table on Market opportunity by End-user ($ million); Exhibits96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits97: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits98: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits99: Chart on Geographic comparison; Exhibits100: Data Table on Geographic comparison; Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on Italy - Market size and forecast 2024-2029 ($ million); Exhibits146: Data Table on Italy - Market size and forecast 2024-2029 ($ million); Exhibits147: Chart on Italy - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on Italy - Year-over-year growth 2024-2029 (%); Exhibits149: Chart on South Korea - Market size and forecast 2024-2029 ($ million)

Search Inside Report

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now